Compliance Rate

Compliance Rate 0%
Compliant submissions 0
Incompliant submissions 0
Total trials 0

My Organizations' Clinical Trials

Showing 250 of 296 entries
View as:

Study of Pexidartinib in Participants With Moderate Hepatic Impairment Compared With Healthy Participants

Phase: N/A Priority: Normal
NCT ID: NCT04223635 Org: User:
Start: 01/07/20 End: 10/02/20 Due: 10/02/21

An Examination of the Safety and Blood Pressure Lowering Effect of Increasing Doses of Benicar® and Benicar® HCT in Patients With Hypertension

Phase: N/A Priority: Normal
NCT ID: NCT00185068 Org: User:
Start: 03/31/04 End: 10/31/04 Due: 10/31/05

Edoxaban vs. Warfarin in Subjects Undergoing Cardioversion of Nonvalvular Atrial Fibrillation (NVAF)

Phase: N/A Priority: Normal
NCT ID: NCT02072434 Org: User:
Start: 03/25/14 End: 02/03/16 Due: 02/03/17

Comparison of Two Doses of Edoxaban Using Different Tests (Assays) and Clinical Outcomes

Phase: N/A Priority: Normal
NCT ID: NCT02964949 Org: User:
Start: 01/24/17 End: 10/09/18 Due: 10/09/19

Pharmacokinetics of Tivantinib in Subjects With Advanced Solid Tumors and Hepatic Impairment

Phase: N/A Priority: Normal
NCT ID: NCT02150733 Org: User:
Start: 04/30/14 End: 07/31/16 Due: 07/31/17

Study of Trastuzumab Deruxtecan, Pembrolizumab, and Platinum-based Chemotherapy in First-line HER2 Overexpressing Non-small Cell Lung Cancer

Phase: N/A Priority: Normal
NCT ID: NCT06899126 Org: User:
Start: 09/07/25 End: 07/05/32 Due: 07/05/33

DX-8951f in Treating Children With Advanced Solid Tumors or Lymphomas

Phase: N/A Priority: Normal
NCT ID: NCT00004212 Org: User:
Start: 09/30/99 End: 04/30/04 Due: 04/30/05

A Dose Finding Study of VN-0200

Phase: N/A Priority: Normal
NCT ID: NCT05547087 Org: User:
Start: 10/13/22 End: 02/15/24 Due: 02/15/25

A Phase 1/2 Study of CS7017, an Oral PPARγ Agonist, in Combination With Paclitaxel

Phase: N/A Priority: Normal
NCT ID: NCT00603941 Org: User:
Start: 01/31/08 End: 12/31/11 Due: 12/31/12

Multiple Ascending Dose Study of DS-1093 in Healthy Subjects

Phase: N/A Priority: Normal
NCT ID: NCT02142400 Org: User:
Start: 05/31/14 End: 02/28/15 Due: 02/28/16

DS-8201a in Pre-treated HER2 Breast Cancer That Cannot be Surgically Removed or Has Spread [DESTINY-Breast02]

Phase: N/A Priority: Normal
NCT ID: NCT03523585 Org: User:
Start: 08/01/18 End: 07/31/25 Due: 07/31/26

A Study to Determine the Effect of WelChol Tablets on Cholesterol in Patients Who Have Been Taking Atorvastatin for at Least 4 Weeks.

Phase: N/A Priority: Normal
NCT ID: NCT00754507 Org: User:
Start: 11/30/02 End: 04/30/05 Due: 04/30/06

Study to Compare Welchol and TriCor to TriCor Alone in Patients With High Cholesterol

Phase: N/A Priority: Normal
NCT ID: NCT00754039 Org: User:
Start: 02/28/03 End: 03/31/04 Due: 03/31/05

DJ-927 as Second-Line Therapy in Treating Patients With Progressive Locally Advanced or Metastatic Colorectal Adenocarcinoma

Phase: N/A Priority: Normal
NCT ID: NCT00080834 Org: User:
Start: 02/29/04 End: 08/31/06 Due: 08/31/07

Combination of Olmesartan and Hydrochlorothiazide in Essential Hypertension

Phase: N/A Priority: Normal
NCT ID: NCT00430950 Org: User:
Start: 02/28/07 End: 10/31/08 Due: 10/31/09

Hokusai Study in Pediatric Patients With Confirmed Venous Thromboembolism (VTE)

Phase: N/A Priority: Normal
NCT ID: NCT02798471 Org: User:
Start: 03/27/17 End: 05/24/22 Due: 05/24/23

Efficacy and Safety of Colesevelam in Pediatric Patients With Genetic High Cholesterol

Phase: N/A Priority: Normal
NCT ID: NCT00145574 Org: User:
Start: 11/30/05 End: 12/31/07 Due: 12/31/08

Medical Access Program for Patritumab Deruxtecan

Phase: N/A Priority: Normal
NCT ID: NCT06099639 Org: User:
Start: - End: - Due: -

Study to Assess the Safety, Pharmacokinetics/Dynamics of DS-1040b in Subjects With Acute Submassive Pulmonary Embolism

Phase: N/A Priority: Normal
NCT ID: NCT02923115 Org: User:
Start: 06/23/16 End: 08/05/19 Due: 08/05/20

Study to Assess Pharmacokinetics, Immunogenicity and Safety/Tolerability of Patritumab (U3-1287)

Phase: N/A Priority: Normal
NCT ID: NCT01957280 Org: User:
Start: 06/30/13 End: 04/30/14 Due: 04/30/15

ARQ 197 for Participants With Relapsed or Refractory Germ Cell Tumors

Phase: N/A Priority: Normal
NCT ID: NCT01055067 Org: User:
Start: 02/02/10 End: 11/30/11 Due: 11/30/12

CS-1008 With Carboplatin/Paclitaxel in Chemotherapy naïve Subjects With Metastatic or Unresectable Non-small Cell Lung Cancer (NSCLC)

Phase: N/A Priority: Normal
NCT ID: NCT00991796 Org: User:
Start: 06/30/09 End: 12/31/11 Due: 12/31/12

DS-1205c With Osimertinib for Metastatic or Unresectable Epidermal Growth Factor Receptor (EGFR)-Mutant Non-Small Cell Lung Cancer

Phase: N/A Priority: Normal
NCT ID: NCT03255083 Org: User:
Start: 04/10/19 End: 09/04/20 Due: 09/04/21

Treatment of High Blood Pressure Using Olmesartan With Hydrochlorothiazide Compared to an ACE Inhibitor With a Calcium Channel Blocker

Phase: N/A Priority: Normal
NCT ID: NCT00185120 Org: User:
Start: 09/30/05 End: 09/30/06 Due: 09/30/07

An Observational Study Investigating the Effectiveness of Pravastatin on Renal Function in Korean Dyslipidemic Patients With Type 2 Diabetes

Phase: N/A Priority: Normal
NCT ID: NCT05107063 Org: User:
Start: 01/20/16 End: 04/19/18 Due: 04/19/19